MGP
PRCT icon

M&G plc’s Procept Biorobotics PRCT Stock Holding History

M&G plc’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-148,331
Closed -$5.34M – 412
2025
Q3 		$5.34M Buy
148,331
+4,772
+3% +$218K 0.03% 268
2025
Q2 		$8.33M Buy
143,559
+13
+0% +$735 0.05% 232
2025
Q1 		$8.33M Buy
143,546
+8,664
+6% +$592K 0.04% 236
2024
Q4 		$10.9M Sell
134,882
-8,683
-6% -$742K 0.07% 193
2024
Q3 		$11.5M Buy
143,565
+4,103
+3% +$291K 0.04% 193
2024
Q2 		$8.51M Buy
+139,462
New +$8.29M 0.03% 230

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

M&G plc's PRCT Position: Q4 2025 in Review

M&G plc sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 148,331 shares — an estimated $5.34M sold.

M&G plc first reported a position in PRCT in Q2 2024 and held it in 6 quarters. The position peaked at $11.5M in Q3 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • M&G plc reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • M&G plc sold 148,331 Procept Biorobotics shares in Q4 2025, an estimated $5.34M.
  • M&G plc first reported a position in Procept Biorobotics in Q2 2024 and held it in 6 quarters.
  • M&G plc's Procept Biorobotics position peaked at $11.5M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on M&G plc's 13F filing for Q4 2025, filed 12 Feb 2026.